Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives

References

• Gorgani L, Mohammadi M, Najafpour GD, et al. Piperine—the bioactive compound of black pepper: from isolation to medicinal formulations. Compr Rev in Food Sci Food Saf. 2017;16:124–140.
   PubMed Web of Science ®Google Scholar
• Meghwal M, Goswami TK. Piper nigrum and piperine: an update. Phytother Res. 2013;27:1121–1130.
   PubMed Web of Science ®Google Scholar
• Srinivasan K. Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crit Rev Food Sci Nutr. 2007;47:735–748.
   PubMed Web of Science ®Google Scholar
• Umar S, Golam Sarwar AH, Umar K, et al. Piperine ameliorates oxidative stress, inflammation and histological outcome in collagen induced arthritis. Cell Immunol. 2013;284:51–59.
   PubMed Web of Science ®Google Scholar
• Koul IB, Kapil A. Evaluation of the liver protective potential of piperine, an active principle of black and long peppers. Planta Med. 1993;59:413–417.
   PubMed Web of Science ®Google Scholar
• Bai YF, Xu H. Protective action of piperine against experimental gastric ulcer. Acta Pharmacol Sin. 2000;21:357–359.
   PubMed Web of Science ®Google Scholar
• Vijayakumar RS, Surya D, Nalini N. Antioxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress. Redox Rep. 2004;9:105–110.
   PubMed Web of Science ®Google Scholar
• Han HK. The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs. Expert Opin Drug Metab Toxicol. 2011;7:721–729.
   PubMed Web of Science ®Google Scholar
• Selvendiran K, Banu SM, Sakthisekaran D. Protective effect of piperine on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Clin Chim Acta. 2004;350:73–78.
   PubMed Web of Science ®Google Scholar
• Singh DV, Godbole MM, Misra K. A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitors. J Mol Model. 2013;19:227–238.
   PubMed Web of Science ®Google Scholar
• Shah SS, Shah GB, Singh SD, et al. Effect of piperine in the regulation of obesity-induced dyslipidemia in high-fat diet rats. Indian J Pharmacol. 2011;43:296–299.
   PubMed Web of Science ®Google Scholar
• Borre YE, Panagaki T, Koelink PJ, et al. Neuroprotective and cognitive enhancing effects of a multi-targeted food intervention in an animal model of neurodegeneration. Neuropharmacology. 2014;79:738–749.
   PubMed Web of Science ®Google Scholar
• Li S, Wang C, Li W, et al. Antidepressant-like effects of piperine and its derivative, antiepilepsirine. J Asian Nat Prod Res. 2007;9:421–430.
   PubMed Web of Science ®Google Scholar
• Li S, Wang C, Wang M, et al. Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms. Life Sci. 2007;80:1373–1381.
   PubMed Web of Science ®Google Scholar
• Chonpathompikunlert P, Wattanathorn J, Muchimapura S. Piperine, the main alkaloid of Thai black pepper, protects against neurodegeneration and cognitive impairment in animal model of cognitive deficit like condition of Alzheimer’s disease. Food Chem Toxicol. 2010;48:798–802.
   PubMed Web of Science ®Google Scholar
• Thiel A, Buskens C, Woehrle T, et al. Black pepper constituent piperine: genotoxicity studies in vitro and in vivo. Food Chem Toxicol. 2014;66:350–357.
   PubMed Web of Science ®Google Scholar
• Bhat GB, Chandrasekhara N. Lack of adverse influence of black pepper, its oleoresin and piperine in the weanling rat. J Food Safety. 1986;7:215–223.
   Web of Science ®Google Scholar
• Bhat BG, Chandrasekhara N. Studies on the metabolism of piperine: absorption, tissue distribution and excretion of urinary conjugates in rats. Toxicology. 1986;40:83–92.
   PubMed Web of Science ®Google Scholar
• Piyachaturawat P, Glinsukon T, Toskulkao C. Acute and subacute toxicity of piperine in mice, rats and hamsters. Toxicol Lett. 1983;16:351–359.
   PubMed Web of Science ®Google Scholar
• Available from: https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm362936.pdf
   Google Scholar
• Rezaee MM, Kazemi S, Kazemi MT, et al. The effect of piperine on midazolam plasma concentration in healthy volunteers, a research on the CYP3A-involving metabolism. Daru. 2014;22:8.
   PubMed Web of Science ®Google Scholar
• Bano G, Amla V, Raina RK, et al. The effect of piperine on pharmacokinetics of phenytoin in healthy volunteers. Planta Med. 1987;53:568–569.
   PubMed Web of Science ®Google Scholar
• Bano G, Raina RK, Zutshi U, et al. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol. 1991;41(6):615–617.
   PubMed Web of Science ®Google Scholar
• Kasibhatta R, Naidu MU. Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions: a randomised, crossover, placebo-controlled study. Drugs R D. 2007;8:383–391.
   PubMedGoogle Scholar
• Shoba G, Joy D, Joseph T, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64:353–356.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Appani R, Boga PK. Effect of piperine on the metabolism and pharmacokinetics of carbamazepine in healthy volunteers. Drug Res (Stuttg). 2017;67:46–51.
   PubMed Web of Science ®Google Scholar
• Koleva II, van Beek TA, Soffers AE, et al. Alkaloids in the human food chain–natural occurrence and possible adverse effects. Mol Nutr Food Res. 2012;56:30–52.
   PubMed Web of Science ®Google Scholar
• Vasavirama K, Upender M. Piperine: a valuable alkaloid from piper species. Int J Pharm Pharm Sci. 2014;6:34–38.
   Google Scholar
• Shao B, Cui C, Ji H, et al. Enhanced oral bioavailability of piperine by self-emulsifying drug delivery systems: in vitro, in vivo and in situ intestinal permeability studies. Drug Deliv. 2015;22:740–747.
   PubMed Web of Science ®Google Scholar
• Prakash UN, Srinivasan K. Beneficial influence of dietary spices on the ultrastructure and fluidity of the intestinal brush border in rats. Br J Nutr. 2010;104:31–39.
   PubMed Web of Science ®Google Scholar
• Sawyer WH. Fluorescence spectroscopy in the study of membrane fluidity. Aloia RC, Curtain CC and Gordon LM (Eds). In: Advances in membrane fluidity. New York: Alan Liss; 1988. p. 161–191.
   Google Scholar
• Carruthers A, Melchior DL. Studies of the relationship between bilayer water permeability and bilayer physical state. Biochemistry. 1983;22:5797–5807.
   Web of Science ®Google Scholar
• Veda S, Srinivasan K. Influence of dietary spices on the in vivo absorption of ingested β-carotene in experimental rats. The British Journal of Nutrition. 2009;105:1429–1438.
   Web of Science ®Google Scholar
• Bajad S, Bedi KL, Singla AK, et al. Piperine inhibits gastric emptying and gastrointestinal transit in rats and mice. Planta Med. 2001;67:176–179.
   PubMed Web of Science ®Google Scholar
• Izzo AA, Capasso R, Pinto L, et al. Effect of vanilloid drugs on gastrointestinal transit in mice. Br J Pharmacol. 2001;132:1411–1416.
   PubMed Web of Science ®Google Scholar
• Estudante M, Morais JG, Soveral G, et al. Intestinal drug transporters: an overview. Adv Drug Deliv Rev. 2013;65:1340–1356.
   PubMed Web of Science ®Google Scholar
• International Transporter Consortium, Giacomini KM, Huang SM, et al.; Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9:215–236.
   PubMed Web of Science ®Google Scholar
• Cascorbi I. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther. 2006;112:457–473.
   PubMed Web of Science ®Google Scholar
• Kim RB, Fromm MF, Wandel C, et al. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J Clin Invest. 1998;101:289–294.
   PubMed Web of Science ®Google Scholar
• Sun J, He ZG, Cheng G, et al. Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med Sci Monit. 2004;10:RA5–RA14.
   PubMed Web of Science ®Google Scholar
• Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev. 2004;36:57–104.
   PubMed Web of Science ®Google Scholar
• Marchetti S, Mazzanti R, Beijnen JH, et al. Concise review: clinical relevance of drug-drug and herb-drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein). Oncologist. 2007;12:927–941.
   PubMed Web of Science ®Google Scholar
• Singh A, Rao AR. Evaluation of the modulatory influence of black pepper (Piper nigrum, L.) on the hepatic detoxication system. Cancer Lett. 1993;72:5–9.
   PubMed Web of Science ®Google Scholar
• Han Y, Chin Tan TM, Lim LY. In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression. Toxicol Appl Pharmacol. 2008;230:283–289.
   PubMed Web of Science ®Google Scholar
• Alzoubi KH, Khabour OF, Al-Azzam SI, et al. The role of multidrug resistance-1 (MDR1) variants in response to fexofenadine among Jordanians. Int J Clin Pharmacol Ther. 2013;51:880–887.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Boga PK. The influence of piperine on the pharmacokinetics of fexofenadine, a P-glycoprotein substrate, in healthy volunteers. Eur J Clin Pharmacol. 2017;73:343–349.
   PubMed Web of Science ®Google Scholar
• Feng X, Liu Y, Wang X, et al. Effects of piperine on the intestinal permeability and pharmacokinetics of linarin in rats. Molecules. 2014;19:5624–5633.
   PubMed Web of Science ®Google Scholar
• Athukuri BL, Neerati P. Enhanced oral bioavailability of domperidone with piperine in male wistar rats: involvement of CYP3A1 and P-gp inhibition. J Pharm Pharm Sci. 2017;20:28–37.
   PubMed Web of Science ®Google Scholar
• Jin MJ, Han HK. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction. J Food Sci. 2010;75:H93–H96.
   PubMed Web of Science ®Google Scholar
• Drescher S, Schaeffeler E, Hitzl M, et al. MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br J Clin Pharmacol. 2002;53:526–534.
   PubMed Web of Science ®Google Scholar
• Qiang F, Kang KW, Han HK. Repeated dosing of piperine induced gene expression of P-glycoprotein via stimulated pregnane-X-receptor activity and altered pharmacokinetics of diltiazem in rats. Biopharm Drug Dispos. 2012;33:446–454.
   PubMed Web of Science ®Google Scholar
• Wang YM, Lin W, Chai SC, et al. Piperine activates human pregnane X receptor to induce the expression of cytochrome P450 3A4 and multidrug resistance protein 1. Toxicol Appl Pharmacol. 2013;272:96–107.
   PubMed Web of Science ®Google Scholar
• Basu S, Jana S, Patel VB, et al. Effects of piperine, cinnamic acid and gallic acid on rosuvastatin pharmacokinetics in rats. Phytother Res. 2013;27:1548–1556.
   PubMed Web of Science ®Google Scholar
• Li S, Lei Y, Jia Y, et al. Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. Phytomedicine. 2011;19:83–87.
   PubMed Web of Science ®Google Scholar
• Wang K, Sun S, Li L, et al. Involvement of organic cation transporter 2 inhibition in potential mechanisms of antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry. 2014;53:90–98.
   PubMed Web of Science ®Google Scholar
• Jancova P, Anzenbacher P, Anzenbacherova E. Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154:103–116.
   PubMed Web of Science ®Google Scholar
• Seviroukova IF, Poulos TL. Understanding the mechanism of cytochrome P450 3A4: recent advences and remaining problems. Dalton Trans. 2013;42:3116–3126.
   PubMed Web of Science ®Google Scholar
• Batt AM, Magdalou J, Vincent-Viry M, et al. Drug metabolizing enzymes related to laboratory medicine: cytochrome P-450 and UDP-glucuronosyltransferase. Clin Chim Acta. 1994;226:171–190.
   PubMed Web of Science ®Google Scholar
• Oda S, Fukami T, Yokoi T, et al. A comprehensive review of UDP glucuronosyltransferase and esterases for drug development. Drug Metab Pharmacokinet. 2015;30:30–51.
   PubMed Web of Science ®Google Scholar
• Singh J, Dubey RK, Atal CK. Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogeneous UDP-glucuronic acid content. J Pharmacol Exp Ther. 1986;236:488–493.
   PubMed Web of Science ®Google Scholar
• Reen RK, Jamwal DS, Taneja SC, et al. Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine. Biochem Pharmacol. 1993;46:229–238.
   PubMed Web of Science ®Google Scholar
• Dalvi RR, Dalvi PS. Comparison of the effects of piperine administered intragastrically and intraperitoneally on the liver and liver mixed-function oxidases in rats. Drug Metabol Drug Interact. 1991;9:23–30.
   PubMedGoogle Scholar
• Kang MH, Won SM, Park SS, et al. Piperine effects on the expression of P4502E1, P4502B and P4501A in rat. Xenobiotica. 1994;24:1195–1204.
   PubMed Web of Science ®Google Scholar
• Fong YK, Li CR, Wo SK, et al. In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of baicalein. J Ethnopharmacol. 2012;141:742–753.
   PubMed Web of Science ®Google Scholar
• Atal CK, Dubey RK, Singh J. Biochemical bases of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Ther. 1985;232:258–262.
   PubMed Web of Science ®Google Scholar
• Makhov P, Golovine K, Canter D, et al. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity. Prostate. 2012;72:661–667.
   PubMed Web of Science ®Google Scholar
• Baker SD, Sparreboom A, Verweij J. Clinical pharmacokinetics of docetaxel: recent developments. Clin Pharmacokinet. 2006;45:235–252.
   PubMed Web of Science ®Google Scholar
• Li C, Wang Q, Ren T, et al. Non-linear pharmacokinetics of piperine and its herb-drug interactions with docetaxel in Sprague-Dawley rats. J Pharm Biomed Anal. 2016;128:286–293.
   PubMed Web of Science ®Google Scholar
• Thummel KE, O’Shea D, Paine MF, et al. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther. 1996;59:491–502.
   PubMed Web of Science ®Google Scholar
• Liang YZ, Chen HM, Su ZQ, et al. White pepper and piperine have different effects on pharmacokinetics of puerarin in rats. Evid Based Complement Alternat Med. 2014;2014:796890.
   PubMed Web of Science ®Google Scholar
• Guerra MC, Speroni E, Broccoli M, et al. Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin: antioxidant properties and effects on rat liver CYP-catalysed drug metabolism. Life Sci. 2000;67:2997–3006.
   PubMed Web of Science ®Google Scholar
• So EL, Ruggles KH, Cascino GD, et al. Seizure exacerbation and status epilepticus related to carbamazepine-10, 11-epoxide. Ann Neurol. 1994;35:743–746.
   PubMed Web of Science ®Google Scholar
• Bhardwaj RK, Glaeser H, Becquemont L, et al. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther. 2002;302:645–650.
   PubMed Web of Science ®Google Scholar
• Veeresham C, Sujatha S, Rani TS. Effect of piperine on the pharmacokinetics and pharmacodynamics of glimepiride in normal and streptozotocin-induced diabetic rats. Nat Prod Commun. 2012;7:1283–1286.
   PubMed Web of Science ®Google Scholar
• Langtry HD, Balfour JA. Glimepiride. A review of its use in the management of type 2 diabetes mellitus. Drugs. 1998;55:563–584.
   PubMed Web of Science ®Google Scholar
• Shamsi S, Tran H, Tan RS, et al. Curcumin, piperine, and capsaicin: a comparative study of spice-mediated inhibition of human cytochrome P450 isozyme activities. Drug Metab Dispos. 2017;45:49–55.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Boga PK, Kotakonda HK. Study on influence of piperine treatment on the pharmacokinetics of diclofenac in healthy volunteers. Xenobiotica. 2017;47:127–132.
   PubMed Web of Science ®Google Scholar
• Venkatesh S, Durga KD, Padmavathi Y, et al. Influence of piperine on ibuprofen induced antinociception and its pharmacokinetics. Arzneimittelforschung. 2011;61:506–509.
   PubMed Web of Science ®Google Scholar
• Klose TS, Ibeanu GC, Ghanayem BI, et al. Identification of residues 286 and 289 as critical for conferring substrate specificity of human CYP2C9 for diclofenac and ibuprofen. Arch Biochem Biophys. 1998;357:240–248.
   PubMed Web of Science ®Google Scholar
• Bedada SK, Boga PK. Effect of piperine on CYP2E1 enzyme activity of chlorzoxazone in healthy volunteers. Xenobiotica. 20167;47:1035–1041.
   Web of Science ®Google Scholar
• Wells PG, Mackenzie PI, Chowdhury JR, et al. Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos. 2004;32:281–290.
   PubMed Web of Science ®Google Scholar
• Di X, Wang X, Di X, et al. Effect of piperine on the bioavailability and pharmacokinetics of emodin in rats. J Pharm Biomed Anal. 2015;115:144–149.
   PubMed Web of Science ®Google Scholar
• Liu W, Feng Q, Li Y, et al. Coupling of UGTs and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin. Toxicol Appl Pharmacol. 2012;265:316–324.
   PubMed Web of Science ®Google Scholar
• Johnson JJ, Nihal M, Siddiqui IA, et al. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res. 2011;55:1169–1176.
   PubMed Web of Science ®Google Scholar
• Brill SS, Furimsky AM, Ho MN, et al. Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms. J Pharm Pharmacol. 2006;58:469–479.
   PubMed Web of Science ®Google Scholar
• Zeng X, Cai D, Zeng Q, et al. Selective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in rat. Biopharm Drug Dispos. 2017;38:3–19.
   PubMed Web of Science ®Google Scholar
• Tonnesen HH, Masson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm. 2002;244:127–135.
   PubMed Web of Science ®Google Scholar
• Garcea G, Jones DJ, Singh R, et al. Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer. 2004;90:1011–1015.
   PubMed Web of Science ®Google Scholar
• Mohanraj V, Chen Y. Nanoparticles – a review. Trop J Pharm Res. 2006;5:561–573.
   Google Scholar
• Son GH, Lee BJ, Cho CW. Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles. J Pharm Invest. 2017;47:287–296.
   Google Scholar
• Pal S, Jana U, Manna P, et al. Nanoparticle: an overview of preparation and characterization. J App Pharm Sci. 2011;01:228–234.
   Google Scholar
• Choi JH, Lee YJ, Kim D. Image-guided nanomedicine for cancer. J Pharm Invest. 2017;47:51–64.
   Google Scholar
• Hoang NH, Lim C, Sim T, et al. Triblock copolymers for nano-sized drug delivery systems. J Pharm Invest. 2017;47:27–35.
   Google Scholar
• Veerareddy PR, Vobalaboina V. Pharmacokinetics and tissue distribution of piperine lipid nanospheres. Pharmazie. 2008;63:352–355.
   PubMed Web of Science ®Google Scholar
• Yusuf M, Khan M, Khan RA, et al. Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model. J Drug Target. 2013;21:300–311.
   PubMed Web of Science ®Google Scholar
• Liu H, Luo R, Chen X, et al. Tissue distribution profiles of three antiparkinsonian alkaloids from Piper longum L. in rats determined by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;928:78–82.
   PubMed Web of Science ®Google Scholar
• Elnaggar YS, Etman SM, Abdelmonsif DA, et al. Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer’s disease: optimization, biological efficacy, and potential toxicity. J Pharm Sci. 2015;104:3544–3556.
   PubMed Web of Science ®Google Scholar
• Pachauri M, Dogra E, Ghosh P. Piperine loaded PEG-PLGA nanoparticles: preparation, characterization and targeted delivery for adjuvant breast cancer chemotherapy. J Drug Deliv Sci Technol. 2015;29:269–282.
   Web of Science ®Google Scholar
• Katiyar SS, Muntimadugu E, Rafeeqi TA, et al. Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment. Drug Deliv. 2016;23:2608–2616.
   PubMed Web of Science ®Google Scholar
• Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007;4:1770–1804.
   PubMed Web of Science ®Google Scholar
• Cherniakov I, Izgelov D, Barasch D, et al. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration. J Control Release. 2017;266:1–7.
   PubMed Web of Science ®Google Scholar
• Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharm. 1997;154:123–140.
   Web of Science ®Google Scholar
• Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10:975–999.
   PubMed Web of Science ®Google Scholar
• Kim JS. Liposomal drug delivery system. J Pharm Invest. 2016;46:387–392.
   Google Scholar
• Kim SY, Lee MK, Lim SJ. Current advances in developing cationic lipid-based nanoparticles as a vehicle for improving adenoviral gene delivery. J Pharm Invest. 2016;46:393–402.
   Google Scholar
• Priprem A, Chonpathompikunlert P, Sutthiparinyanont S, et al. Antidepressant and cognitive activities of intranasal piperine-encapsulated liposomes. Adv Biosci Biotechnol. 2011;2:108–116.
   Google Scholar
• Raay B, Medda S, Mukhopadhyay S, et al. Targeting of piperine intercalated in mannose-coated liposomes in experimental leishmaniasis. Indian J Biochem Biophys. 1999;36:248–251.
   PubMed Web of Science ®Google Scholar
• Dutta S, Bhattacharjee P. Nanoliposomal encapsulates of piperine-rich black pepper extract obtained by enzyme-assisted supercritical carbon dioxide extraction. J Food Eng. 2017;201:49–56.
   Web of Science ®Google Scholar
• Pentak D. In vitro spectroscopic study of piperine-encapsulated nanosize liposomes. Eur Biophys J. 2016;45:175–186.
   PubMed Web of Science ®Google Scholar
• Callender SP, Mathews JA, Kobernyk K, et al. Microemulsion utility in pharmaceuticals: implications for multi-drug delivery. Int J Pharm. 2017;526:425–442.
   PubMed Web of Science ®Google Scholar
• Bibette J, Calderon F, Poulin P. Emulsions: basic principles. Rep. Prog. Phys. 1999;62:969.
   Web of Science ®Google Scholar
• Park S, Lee SE, Lee JK, et al. Preparation and, physicochemical characterization of ketoprofen-loaded emulsions. J Pharm Invest. 2016;46:487–493.
   Google Scholar
• Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173–182.
   PubMed Web of Science ®Google Scholar
• Dangre PV, Gilhotra RM, Dhole SN. Formulation and development of solid self micro-emulsifying drug delivery system (S-SMEDDS) containing chlorthalidone for improvement of dissolution. J Pharm Invest. 2016;46:633–644.
   Google Scholar
• Kohli K, Chopra S, Dhar D, et al. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov Today. 2010;15:958–965.
   PubMed Web of Science ®Google Scholar
• Qi X, Wang L, Zhu J, et al. Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability. Int J Pharm. 2011;409:245–251.
   PubMed Web of Science ®Google Scholar
• Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6:231–248.
   PubMed Web of Science ®Google Scholar
• Grill AE, Koniar B, Panyam J. Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin. Drug Deliv Transl Res. 2014;4:344–352.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhai W, Jiang Q, et al. Curcumin-piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy. Int J Pharm. 2015;490:22–31.
   PubMed Web of Science ®Google Scholar
• Gulseren I, Guri A, Corredig M. Effect of interfacial composition on uptake of curcumin-piperine mixtures in oil in water emulsions by Caco-2 cells. Food Funct. 2014;5:1218–1223.
   PubMed Web of Science ®Google Scholar
• Rastogi V, Shukla S, Singh R, et al. Microspheres: a promising drug carrier. J Drug Deliv Ther. 2016;6:18–26.
   Google Scholar
• Prajapati VD, Jani GK, Kapadia JR. Current knowledge on biodegradable microspheres in drug delivery. Expert Opin Drug Deliv. 2015;12:1283–1299.
   PubMed Web of Science ®Google Scholar
• Odeku OA, Aderogba AA, Ajala TO, et al. Formulation of floating metronidazole microspheres using cassava starch (Manihot esculenta) as polymer. J Pharm Invest. 2017;47:445–451.
   Google Scholar
• Boddupalli B, Ramani R, Subramaniam B, et al. In vitro and invivo evaluation of hepato protection and anti ulceractivities of piperine gastro retentive micropspheres. Asian Pac J Trop Biomed. 2012;2:1237–1240.
   Google Scholar
• Khatri S, Awasthi R. Piperine containing floating microspheres: an approach for drug targeting to the upper gastrointestinal tract. Drug Deliv Transl Res. 2016;6:299–307.
   PubMed Web of Science ®Google Scholar
• Ratanavaraporn J, Kanokpanont S, Damrongsakkul S. The development of injectable gelatin/silk fibroin microspheres for the dual delivery of curcumin and piperine. J Mater Sci Mater Med. 2014;25:401–410.
   PubMed Web of Science ®Google Scholar
• Ridhurkar D, Vajdai A, Zsigmond Z. Hot-melt extrusion (HME)and its application for pharmacokinetic improvement of poorly water soluble drugs. PTB Reports. 2016;2:47–51.
   Google Scholar
• Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007;12:1068–1075.
   PubMed Web of Science ®Google Scholar
• Nguyen MN, Vo TV, Tran PHL, et al. Zein-based solid dispersion for potential application in targeted delivery. J Pharm Invest. 2017;47:357–364.
   Google Scholar
• Kim S, Gupta B, Moon C, et al. Employing an optimized spray-drying process to produce ezetimibe tablets with an improved dissolution profile. J Pharm Invest. 2016;46:583–592.
   Google Scholar
• Choi YH, Chin YW, Yang SJ, et al. Isolation of a lignan-enriched fraction from Schisandra chinensis and its effective solubilization via poloxamer 407-based solid dispersion formulation. J Pharm Invest. 2016;46:133–138.
   Google Scholar
• Ashour EA, Majumdar S, Alsheteli A, et al. Hot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperine. J Pharm Pharmacol. 2016;68:989–998.
   PubMed Web of Science ®Google Scholar
• Zulal N, Lakshmi P. Enhancement of solubility and bioavailability of candesartan cilexetil using natural P-glycoprotein inhibitors. Trop J Pharm Res. 2015;14:21–26.
   Web of Science ®Google Scholar
• Raza K, Kumar D, Kiran C, et al. Conjugation of docetaxel with multiwalled carbon nanotubes and codelivery with piperine: implications on pharmacokinetic profile and anticancer activity. Mol Pharm. 2016;13:2423–2432.
   PubMed Web of Science ®Google Scholar
• Jain S, Meka SRK, Chatterjee K. Engineering a piperine eluting nanofibrous patch for cancer treatment. ACS Biomater Sci Eng. 2016;2:1376–1385.
   Web of Science ®Google Scholar